SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11044537
Source:
http://linkedlifedata.com/resource/pubmed/id/11044537
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0032961
,
umls-concept:C0040038
,
umls-concept:C0087111
,
umls-concept:C0199176
,
umls-concept:C0206461
pubmed:issue
1
pubmed:dateCreated
2000-11-22
pubmed:abstractText
To determine if a prophylactic dose of dalteparin, 5000 IU daily, and if the adjusted-weight dalteparin therapeutic dose of 100 IU/kg twice daily are appropriate in pregnancy.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0210174
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants
,
http://linkedlifedata.com/resource/pubmed/chemical/Dalteparin
,
http://linkedlifedata.com/resource/pubmed/chemical/Insect Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/Salivary Proteins and Peptides
,
http://linkedlifedata.com/resource/pubmed/chemical/anticoagulant factor Xa protein...
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0020-7292
pubmed:author
pubmed-author:RivardG EGE
,
pubmed-author:SHOYY
pubmed:issnType
Print
pubmed:volume
71
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
19-24
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:11044537-Adult
,
pubmed-meshheading:11044537-Anticoagulants
,
pubmed-meshheading:11044537-Body Mass Index
,
pubmed-meshheading:11044537-Body Weight
,
pubmed-meshheading:11044537-Dalteparin
,
pubmed-meshheading:11044537-Drug Monitoring
,
pubmed-meshheading:11044537-Female
,
pubmed-meshheading:11044537-Follow-Up Studies
,
pubmed-meshheading:11044537-Humans
,
pubmed-meshheading:11044537-Injections, Subcutaneous
,
pubmed-meshheading:11044537-Insect Proteins
,
pubmed-meshheading:11044537-Platelet Count
,
pubmed-meshheading:11044537-Pregnancy
,
pubmed-meshheading:11044537-Pregnancy Complications, Hematologic
,
pubmed-meshheading:11044537-Pregnancy Outcome
,
pubmed-meshheading:11044537-Pregnancy Trimester, Third
,
pubmed-meshheading:11044537-Salivary Proteins and Peptides
,
pubmed-meshheading:11044537-Thromboembolism
,
pubmed-meshheading:11044537-Weight Gain
pubmed:year
2000
pubmed:articleTitle
Prophylaxis and treatment of thromboembolic diseases during pregnancy with dalteparin.
pubmed:affiliation
Department of Obstetrics and Gynecology, Saint Justine Hospital, Quebec, Montreal, Canada. evelyne-rey@ssss.gouv.qc.ca
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Controlled Clinical Trial
,
Research Support, Non-U.S. Gov't